16min chapter

Blood Cancer Talks cover image

Episode 36. ASH 2023 Lymphoma Recap with Dr. Toby Eyre

Blood Cancer Talks

CHAPTER

Comparing FCR and M.R.D.-guided therapy in CLL patients

In this chapter, the hosts discuss the FLAIR trial, a large UK multi-center adaptive trial in CLL. They talk about the comparison between FCR (chemo immunotherapy) and M.R.D.-guided duration of broungeb-plus-videclacks therapy in untreated CLL patients. They delve into the performance of M.R.D. in both peripheral blood and bone marrow, the relevance of M.R.D. in the CLL context, and the potential benefits of personalized therapy. They also discuss the implications of the study results and the future of M.R.D. testing in CLL treatment.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode